Atazanavir Sulfate Capsule
Product Images NDC 65862-710

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Atazanavir Sulfate (NDC 65862-710). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure-1 (Atazanavir Fig1)

A line graph comparing atazanavir plasma concentration (ng/mL) over time (hours) for two dosing regimens: ATV 400 mg and ATV/RTV 300/100 mg. The y-axis is logarithmic, ranging from 1 to 10,000 ng/mL. Both curves show peak concentrations within the first 4 hours. Error bars indicate variability; sample sizes are n=10 for ATV 400 mg and n=13 for ATV/RTV 300/100 mg. A horizontal line marks the median wild-type EC90 of 14 ng/mL.*

FDA Label Image

Ckage Label-principal Display Panel (100 mg (60 Capsules Bottle))

Label for Atazanavir Capsules 100 mg, a drug for further processing in capsule form. The label indicates the active ingredient as atazanavir sulfate equivalent to 100 mg atazanavir per capsule. It is distributed by Aurobindo Pharma USA, Inc. with manufacturing in India. The label includes a barcode, a warning box in red about drug interactions, and storage instructions for controlled room temperature. Package count is 60 capsules.*

FDA Label Image

Package Label-principal Display Panel (100 mg (3 x 10) Unit-dose Capsules)

Label for Atazanavir Capsules 100 mg as a unit-dose package containing 30 capsules (3 x 10). The label includes storage instructions, dosage reference, pediatric safety warning, and a pharmacist alert regarding drug interactions. Distributed by Aurobindo Pharma USA, Inc., made in India, with an NDC of 65862-710-03.*

FDA Label Image

Figure 4 (Atazanavir Fig4)

Label for Atazanavir Capsules 150 mg, a drug for further processing supplied by Aurobindo Pharma Limited. The label includes NDC 65862-711-60, states each capsule contains Atazanavir sulfate equivalent to 150 mg Atazanavir, and cautions about medicine interactions and pharmacist alert coverage. It indicates storage conditions, distributor details, and package size of 60 capsules.*

FDA Label Image

Package Label-principal Display Panel (150 mg (3 x 10) Unit-dose Capsules)

Packaging label for Atazanavir Capsules 150 mg by Aurobindo Pharma Limited. The label indicates the strength of 150 mg per capsule and states the contents as 30 (3 x 10) unit-dose capsules. It includes storage instructions, a warning to keep out of reach of children, and an alert box advising pharmacists about medicines that should not be taken with Atazanavir Capsules. The label also includes the NDC 65862-711-03 and distributor information for Aurobindo Pharma USA, Inc.*

FDA Label Image

Package Label-principal Display Panel (200 mg (60 Capsules Bottle))

Atazanavir Capsules 200 mg packaging label showing prescription-only drug for further processing by Aurobindo Pharma Limited. The label indicates that each capsule contains 200 mg of atazanavir sulfate, with a package size of 60 capsules. Storage instructions are provided, along with warnings to keep out of reach of children and alerts about drug interactions. The label includes distributor information and a barcode.*

FDA Label Image

Package Label-principal Display Panel (200 mg (3 x 10) Unit-dose Capsules)

Packaging label for Atazanavir Capsules 200 mg, containing 30 unit-dose capsules (3 x 10). The label includes storage instructions, a pharmacist alert box regarding medicine interactions, and distributor details for Aurobindo Pharma USA, Inc. The product is made in India and is Rx only.*

FDA Label Image

Package Label-principal Display Panel (300 mg (3 x 10) Unit-dose Capsules)

Packaging label for Atazanavir Capsules 300 mg by Aurobindo Pharma Limited. The label includes the NDC number 65862-713-30 and states each capsule contains Atazanavir sulfate equivalent to 300 mg Atazanavir. It has storage instructions, a warning about drug interactions, and distribution information from Aurobindo Pharma USA, Inc.*

FDA Label Image

Package Label-principal Display Panel (300 mg (3 x 10) Unit-dose Capsules)

Atazanavir Capsules 300 mg unit-dose packaging label from Aurobindo Pharma Limited. The label shows 30 capsules in 3 blister packs of 10 each. It includes storage instructions, dosage reference to the package insert, a pharmacist alert about drug interactions, and distributor information for Aurobindo Pharma USA, Inc. The label also features the NDC 65862-713-03 barcode.*

FDA Label Image

Chemical Structure (Atazanavir Str)

Chemical structure of Atazanavir, a drug for further processing in capsule form by Aurobindo Pharma Limited. The diagram shows the arrangement of atoms and bonds characteristic to Atazanavir's molecular composition.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.